Nestory Masalu

Nestory Masalu

Auto-generated profile, based on publicly available information

Nestory Masalu

Catholic University of Health and Allied Sciences, Bugando Medical Center, Mwanza, Tanzania

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in JCO Global Oncology
Verified
Journal Article
Open access
LMLuke Maillie
Luke Maillie
NMNestory Masalu
Nestory Masalu
JMJudy Mafwimbo
Judy Mafwimbo
MMMastidia Maxmilian
Mastidia Maxmilian
KSKristin Schroeder
Kristin Schroeder
PURPOSE: It is estimated that 50%-80% of patients with pediatric cancer in sub-Saharan Africa present at an advanced stage. Delays can occur at any time during the care-seeking process from symptom onset to treatment initiation. Referral delay, the time from first presentation at a health facility to oncologist evaluation, is a key component of total delay that has not been evaluated in sub-Saharan Africa. METHODS: Over a 3-month period, caregivers of children diagnosed with cancer at a regional cancer center (Bugando Medical Centre [BMC]) in Tanzania were consecutively surveyed to determine the number and type of health facilities visited before presentation, interventions received, and transportation used to reach each facility. RESULTS: Forty-nine caregivers were consented and included in the review. A total of 124 facilities were visited before BMC, with 31% of visits (n = 38) resulting in a referral. The median referral delay was 89 days (mean, 122 days), with a median of two facilities (mean, 2.5 facilities) visited before presentation to BMC. Visiting a traditional healer first significantly increased the time taken to reach BMC compared with starting at a health center/dispensary (103 v 236 days; P = .02). Facility visits in which a patient received a referral to a higher-level facility led to significantly decreased time to reach BMC ( P < .0001). Only 36% of visits to district hospitals and 20.6% of visits to health centers/dispensaries yielded a referral, however. CONCLUSION: The majority of patients were delayed during the referral process, but receipt of a referral to a higher-level facility significantly shortened delay time. Referral delay for pediatric patients with cancer could be decreased by raising awareness of cancer and strengthening the referral process from lower-level to higher-level facilities.

4 January 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
DADino Amadori
Dino Amadori
PSPatrizia Serra
Patrizia Serra
NMNestory Masalu
Nestory Masalu
APAkwilina Pangan
Akwilina Pangan
ESEmanuela Scarpi
Emanuela Scarpi
LMLaura Mercatali
Laura Mercatali
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Dino Amadori1, Patrizia Serra2, Nestory Masalu3, Akwilina Pangan3, Emanuela Scarpi2, Aloyce Maria Bugingo3, Deogratias Katabalo3, Toni Ibrahim4, Alberto Bongiovanni4, Giacomo Miserocchi4, Chiara Spadazzi4, Chiara Liverani4, Valentina Turri5, Rosanna Tedaldi1, Laura Mercatali4 1Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy 2Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy 3Department of Oncology, Bugando Medical Center, Mwanza, Tanzania, Africa 4Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy 5Healthcare Administration, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy Correspondence to: Dino Amadori, email: dino.amadori@irst.emr.it Keywords: Africans, caucasians, 25(OH)D, vitamin D pathway, vitamin D binding protein Received: September 27, 2016 Accepted: December 15, 2016 Published: January 04, 2017 ABSTRACT As total vitamin D levels are often lower in black than in white Americans, the former are frequently classified as vitamin D-deficient. To fully understand African vitamin D (25(OH)D) status, other factors should be considered, e.g. vitamin D blood carrier, vitamin D-binding protein (DBP), vitamin D receptor (VDR) and DBP polymorphisms. A prospective study on an indigenous black Tanzanian and a Caucasian Italian population was performed on 50 healthy donors from both populations and 35 Caucasian and 18 African breast cancer patients. 25(OH)D and DBP serum levels were analyzed by ELISA. A1012G, Cdx2 and Fok1 VDR polymorphisms and DBP polymorphisms rs4588 and rs7041 were genotyped by real-time PCR. Vitamin D and DBP levels were lower in healthy African donors than in Caucasians. Africans had a significantly higher frequency of AA and CC for Cdx2 and Fok1 polymorphisms, respectively. These allelic variants were related to a higher transcription of VDR gene and a higher activity of VDR receptor. With regard to polymorphism distribution, Africans showed innate higher levels and activity of VDR. We conclude that a strengthening of the vitamin D pathway could have a protective role against the development of breast cancer in the African population.

29 March 2018 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
SBSara Bravaccini
Sara Bravaccini
SRSara Ravaioli
Sara Ravaioli
DADino Amadori
Dino Amadori
ESEmanuela Scarpi
Emanuela Scarpi
MPMaurizio Puccetti
Maurizio Puccetti
GBGiuseppe Bronte
Giuseppe Bronte
Purpose: Androgen receptor (AR) has been shown to have prognostic implication on breast cancer (BC). Data on the biological features of African BCs are poor. We decided for the first time to compare AR expression of Tanzanian and Italian BC patients. Patients and methods: Of the 69 consecutive patients seen at the Bugando Medical Center (Mwanza, Tanzania) from 2003 to 2010, who underwent resection of primary BC evaluable for estrogen receptor, progesterone receptor (PgR), and HER2 only 65 were evaluable for AR by immunohistochemistry. Histopathological assessment and biomolecular determinations were performed at the Cancer Institute of Romagna [Istituto Scientifico Romagnolo per lo studio e la cura dei tumori (IRST)—IRCCS, Meldola, Italy]. Caucasian BC patients were selected from an electronic database and matched (1:2 ratio) for year of diagnosis and age at diagnosis. Results: The median age of patients at diagnosis was 51 (range 29–83) years for Tanzanian and 53 (range 26–86) years for Italian patients. Tanzanian patients harbored tumors with lower AR expression than Italian patients according to the median percentage of immunopositive tumor cells (30% versus 80%, p < 0.0001) and staining intensity (p = 0.0003). The proportion of AR negative patients was likewise higher among Tanzanian patients as regards both ≥1% and ≥10% cutoffs. AR-positive BCs were higher in luminal A and B tumors and decreased in triple-negative (TN) and HER2-enriched tumors in Tanzanian population. Conclusion: AR loss could represent an unfavorable prognostic marker in the African population. The high frequency of TN tumors with high AR expression could open new perspectives of therapy for population in this low income country.

1 June 2023 in JCO Global Oncology
Verified
Journal Article
Open access
LDLynne Davies
Lynne Davies
DMDanny A. Milner
Danny A. Milner
LSLawrence N. Shulman
Lawrence N. Shulman
LKLynnette Kyokunda
Lynnette Kyokunda
ABAlemayehu Bedada
Alemayehu Bedada
UDUte Dugan
Ute Dugan
PURPOSE: To evaluate the scope and types of cancer research projects in sub-Saharan Africa (SSA) to identify research gaps and inform future efforts. METHODS: This retrospective observational study summarized information on cancer research projects in SSA from the International Cancer Research Partnership (ICRP) between 2015 and 2020, alongside 2020 cancer incidence and mortality data from the Global Cancer Observatory. SSA cancer research projects were identified as led by investigators in SSA countries, or by investigators in non-SSA countries with collaborators in SSA, or in database keyword searches. Projects from the Coalition for Implementation Research in Global Oncology (CIRGO) were also summarized. RESULTS: A total of 1,846 projects were identified from the ICRP database, funded by 34 organizations in seven countries (only one, Cancer Association of South Africa, based in SSA); only 156 (8%) were led by SSA-based investigators. Most projects focused on virally induced cancers (57%). Across all cancer types, projects were most frequently related to cervical cancer (24%), Kaposi sarcoma (15%), breast cancer (10%), or non-Hodgkin lymphoma (10%). Gaps were observed for several cancers with higher incidence/mortality burden in SSA; for example, prostate cancer accounted for only 4% of projects but 8% of cancer-related deaths and 10% of new cases. Approximately 26% were dedicated to etiology. Treatment-related research declined over the study period (14%-7% of all projects), while projects related to prevention (15%-20%) and diagnosis/prognosis (15%-29%) increased. Fifteen CIRGO projects were identified; seven were relevant across multiple cancer types, and 12 focused either wholly or partially on cancer control (representing 50% of the total research effort). CONCLUSION: This analysis shows notable discrepancies between cancer burden and research projects and identifies opportunities for future strategic investments in cancer care in SSA.

1 March 2023 in JCO Global Oncology
Verified
Journal Article
Open access
TFTara M. Friebel-Klingner
Tara M. Friebel-Klingner
EJEmma Joo
Emma Joo
MKMatogoro Kirahi
Matogoro Kirahi
LPLydia E. Pace
Lydia E. Pace
EPElizabeth A. Platz
Elizabeth A. Platz
ARAnne F. Rositch
Anne F. Rositch
PURPOSE: In Tanzania, high breast cancer mortality can be attributed to delays in diagnosis and treatment initiation. We adapted the cascade analysis method to depict sequential steps along the breast cancer care pathway in a tertiary hospital in Mwanza, to identify where correction of loss to attrition would have the biggest impact on improving outcomes. METHODS: This prospective cohort included adult women presenting with breast concerns between February 2020 and January 2022. Five cascade steps beginning with patients' initial clinical breast assessment (CBA) through cancer treatment were identified: (1) CBA, (2) ordering diagnostic test(s), (3) completion of diagnostic test(s), (4) receipt of final diagnosis, and (5) initiating cancer treatment. RESULTS: Overall, 721 eligible women with a median age of 42.8 years (IQR, 32.5-55.0) were included. Median time from presentation to treatment initiation was 35 days (IQR, 20-63). For step 1, 39.1% (n = 282) of patients were diagnosed with a benign concern and removed from the cascade. Completion rates for steps 2-4 were 95.0%, 90.2%, and 91.0, respectively. There were 156 (45.6%) patients diagnosed with breast cancer, and for step 5, 71.2% of patients initiated cancer treatment. In steps 2, 3, 4, and 5, there was a loss of 22, 41, 34, and 45 patients, respectively. If loss was eliminated at steps 2, 3, 4, or 5, an additional 6, 12, 11, or 45 patients, respectively, would have completed the pathway. CONCLUSION: Initiating cancer treatment was identified as the step with the biggest loss and, if remedied, would have the biggest impact on improving breast cancer outcomes at Bugando Medical Centre. These results will inform future programs focused on reducing overall loss in the system and supporting patients with breast cancer.

26 September 2015 in Annals of Oncology
Verified
Journal Article
Closed access
PDF file
MBM. Botteghi
M. Botteghi
NMN. Masalu
N. Masalu
RTR. Tumino
R. Tumino
MPM. Puccetti
M. Puccetti
PSPatrizia Serra
Patrizia Serra
DAD. Amadori
D. Amadori
Background: The incidence of tumors in developing countries is dramatically increasing;the ability to provide early diagnosis, treatments, follow-up care and the availability of reliable epidemiological data has a strong impact on the cancer survival.Although telemedicine implementation largely remains a privilege of developed countries,it could be of great utility and efficacy in developing countries lacking appropriate health care facilities by allowing for the performance of good level health care practices. There is currently a longstanding partnership between IRST and the Bugando Medical Centre - Mwanza, Tanzania (BMC).“Share & Meet” project includes a novel telematics platform oriented to oncology and its related branches. We are developing the project between BMC departments and Italian stakeholders with cooperative programs including training of medical staff through e-learning programs,remote pathology diagnosis and other e-oncology applications